In this study we investigated APOBEC3B mRNA expression levels in synchronous DCIS and IBC and correlated the expression with PIK3CA mutation status in order to increase our understanding regarding the expression levels of this enzyme during progression from the in situ to the invasive stage. The gene discussed is APOBEC3B; the disease is inflammatory breast carcinoma.